-
1Academic Journal
Συγγραφείς: Lysakova E.V., Burak M.Y., Navrotsky M.B., Rybtsov S.A.
Συνεισφορές: 0
Πηγή: Russian Journal of Infection and Immunity; Vol 15, No 3 (2025); 446-464 ; Инфекция и иммунитет; Vol 15, No 3 (2025); 446-464 ; 2313-7398 ; 2220-7619
Θεματικοί όροι: genetic instability, age-associated pathologies, retroelements, retroviruses, oncoviruses, reverse transcriptase inhibitor, senescence, vaccination, preventive medicine, генетическая нестабильность, возрастные патологии, ретроэлементы, ретровирусы, онковирусы, ингибитор обратной транскриптазы, сенесцентность, вакцинация, профилактическая медицина
Περιγραφή αρχείου: application/pdf
Relation: https://iimmun.ru/iimm/article/view/17834/2184; https://iimmun.ru/iimm/article/view/17834/2293; https://iimmun.ru/iimm/article/downloadSuppFile/17834/138572; https://iimmun.ru/iimm/article/downloadSuppFile/17834/138573; https://iimmun.ru/iimm/article/downloadSuppFile/17834/138574; https://iimmun.ru/iimm/article/downloadSuppFile/17834/138575; https://iimmun.ru/iimm/article/downloadSuppFile/17834/138576; https://iimmun.ru/iimm/article/downloadSuppFile/17834/138589; https://iimmun.ru/iimm/article/downloadSuppFile/17834/138590; https://iimmun.ru/iimm/article/downloadSuppFile/17834/138591; https://iimmun.ru/iimm/article/downloadSuppFile/17834/138592; https://iimmun.ru/iimm/article/downloadSuppFile/17834/139263; https://iimmun.ru/iimm/article/downloadSuppFile/17834/139264; https://iimmun.ru/iimm/article/view/17834
-
2Academic Journal
Συγγραφείς: V. V. Erdman, D. D. Karimov, I. A. Tuktarova, Y. R. Timasheva, T. R. Nasibullin, O. E. Mustafina, В. В. Эрдман, Д. Д. Каримов, И. А. Туктарова, Я. Р. Тимашева, Т. Р. Насибуллин, О. Е. Мустафина
Πηγή: Medical Genetics; Том 19, № 9 (2020); 50-53 ; Медицинская генетика; Том 19, № 9 (2020); 50-53 ; 2073-7998
Θεματικοί όροι: Alu-элемент, longevity, genetic instability, transposon, Alu-element, долголетие, генетическая нестабильность, транспозон
Περιγραφή αρχείου: application/pdf
Διαθεσιμότητα: https://www.medgen-journal.ru/jour/article/view/1707
-
3Academic Journal
Συγγραφείς: E. P. Kharchenko, I. A. Solov’ev, Е. П. Харченко, И. А. Соловьев
Πηγή: Surgery and Oncology; Том 7, № 4 (2017); 11-19 ; Хирургия и онкология; Том 7, № 4 (2017); 11-19 ; 2949-5857 ; 10.17650/2220-3478-2017-7-4
Θεματικοί όροι: колоректальный рак, immune system, genetic instability, colorectal cancer, генетическая нестабильность, иммунная система
Περιγραφή αρχείου: application/pdf
Relation: https://www.onco-surgery.info/jour/article/view/230/191; De Rosa M., Rega D., Costabile V. et al. The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care. Ther Adv Gastroenterol 2016;9(6):861–86. DOI:10.1177/1756283X16659790.; Харченко E.П. Канцерогенез: иммунная система и иммунотерапия. Иммунология 2011;32(1):50–6. [Kharchenko E.P. Carcinogenesis: the immune system and immunotherapy. Immunologiya = Immunology 2011;32(1):50–6. (In Russ.)].; Irrazábal T., Belcheva A., Girardin S.E. et al. The multifaceted role of the intestinal microbiota in colon cancer. Molecular Cell 2014;54(2):309–20. DOI:10.1016/j.molcel.2014.03.039.; Makkouk A., Weiner G.J. Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge. Cancer Res 2014;75(1):5–10. DOI:10.1158/0008-5472.CAN-14-2538.; Ha C., Lam Y.Y., Holmes A.J. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol 2014;20(44):16498–517. DOI:10.3748/wjg.v20.i44.16498.; Pflughoeft K.J., Versalovic J. Human microbiome in health and disease. Annu Rev Pathol 2012;7:99–122. DOI:10.1146/annurev-pathol-011811-132421.; McDermott A.J., Huffnagle G.B. The microbiome and regulation of mucosal immunity. Immunology 2013;142(1):24–31. DOI:10.1111/imm.12231.; Jandhyala S.M., Talukdar R., Subramanyam C. et al. Role of the normal gut microbiota World J Gastroenterol 2015;21(29):8787–803. DOI:10.3748/wjg.v21.i29.8787.; Dzutsev A., Goldszmid R.S., Viaud S. et al. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol 2015;45(1):17–31. DOI:10.1002/eji.201444972.; Cadwell K. The virome in host health and disease. Immunity 2015;42(5):805–13. DOI:10.1016/j.immuni.2015.05.003.; Gagnière J., Raisch J., Veziant J. et al. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol 2016;22(2):501–18. DOI:10.3748/wjg.v22.i2.501.; Tojo R., Suárez A., Clemente M.G. et al. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol 2014;20(41):15163–76. DOI:10.3748/wjg.v20.i41.15163.; Bäumler A.J., Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature 2016;535(7610):85–93. DOI:10.1038/nature18849.; Eloe-Fadrosh E.A., Rasko D.A. The human microbiome: from symbiosis to pathogenesis. Annu Rev Med 2013;64:145–63. DOI:10.1146/annurev-med-010312-133513.; Forbes J.D., Van Domselaar G., Bernstein C.N. The gut microbiota in immunemediated inflammatory diseases. Front Microbiol 2016;7:1081. DOI:10.3389/fmicb.2016.01081.; Peterson C.T., Sharma V., Elmén L., Peterson S.N. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol 2014;179(3):363–77. DOI:10.1111/cei.12474.; Muszer M., Noszczyńska M., Kasperkiewicz K. et al. Human microbiome: when a friend becomes an enemy. Arch Immunol Ther Exp 2015;63(4):287–98. DOI:10.1007/s00005-015-0332-3.; Fardini Y., Wang X., Temoin S. et al. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol 2011;82(6):1468–80. DOI:10.1111/j.1365-2958.2011.07905.x.; Rubinstein M.R., Wang X., Liu W. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/b-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14(2):195–206. DOI:10.1016/j.chom.2013.07.012.; Wu S., Morin P.J., Maouyo D. et al. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 2003;124(2):392–400. DOI:10.1053/gast.2003.50047.; Lundberg J.O., Weitzberg E., Cole J.A. et al. Nitrate, bacteria and human health. Nat Rev Microbiol 2004;2(7):593–602. DOI:10.1038/nrmicro929.; Sobko T., Huang L., Midtvedt T. et al. Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic Biol Med 2006;41(6):985–91. DOI:10.1016/j.freeradbiomed.2006.06.020.; Huycke M.M., Moore D.R. In vivo production of hydroxyl radical by Enterococcus faecalis colonizing the intestinal tract using aromatic hydroxylation. Free Radic Biol Med 2002;33(6):818–26.; Arthur J.C., Perez-Chanona E., Muhlbauer M. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338(6103):120–3. DOI:10.1126/science.1224820.; Carman R.J., van Tassell R.L., Kingston D.G. et al. Conversion of IQ, a dietary pyrolysis carcinogen to a direct-acting mutagen by normal intestinal bacteria of humans. Mutat Res 1988;206(3):335–42.; De Kok T.M., van Maanen J.M., Lankelma J. et al. Electron spin resonance spectroscopy of oxygen radicals generated by synthetic fecapentaene-12 and reduction of fecapentaene mutagenicity to Salmonella typhimurium by hydroxyl radical scavenging. Carcinogenesis 1992;13(7):1249–55. PMID: 1322251.; Salaspuro M. Bacteriocolonic pathway for ethanol oxidation: characteristics and implications. Ann Med 1996;28(3):195–200. PMID: 8811162.; Choi S.W., Mason J.B. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002;132(8 suppl):2413S–8S. PMID: 12163703.; Deplancke B., Finster K., Graham W.V. et al. Gastrointestinal and microbial responses to sulfate supplemented drinking water in mice. Exp Biol Med (Maywood) 2003;228(4):424–33. PMID: 12671187.; Christl S.U., Scheppach W., Kasper H. Hydrogen metabolism in the large intestine – physiology and clinical implications. Z Gastroenterol 1995;33(7):408–13. PMID: 7571760.; Gill C.I., Rowland I.R. Diet and cancer: assessing the risk. Br J Nutr 2002;88(suppl 1): S73–87. DOI:10.1079/BJN2002632.; Hague A., Manning A.M., Hanlon K.A. et al. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 1993;55(3):498–505. PMID: 8397167.; Caderni G., De Filippo C., Luceri et al. Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 2000;21(11):1965–9. PMID: 11062155.; Yamamoto M., Matsumoto S. Gut microbiota and colorectal cancer. Genes Environ 2016;38:11. DOI:10.1186/s41021-016-0038-8.; Formica V., Cereda V., Nardecchia A. et al. Immune reaction and colorectal cancer: friends or foes? World J Gastroenterol 2014;20(35):12407–19. DOI:10.3748/wjg.v20.i35.12407.; Pernot S., Terme M., Voron T. et al. Colorectal cancer and immunity: what we know and perspectives. World J Gastroenterol 2014;20(14):3738–50. DOI:10.3748/wjg.v20.i14.3738.; De Vries N.L., Swets M., Vahrmeijer A.L. et al. The immunogenicity of colorectal cancer in relation to tumor development and treatment. Int J Mol Sci 2016;17(7):1030. DOI:10.3390/ijms17071030.; Mármol I., Sánchez-de-Diego C., Pradilla Dieste A. et al. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci 2017;18(1):E197. DOI:10.3390/ijms18010197.; Ballester V., Rashtak S., Boardman L. Clinical and molecular features of youngonset colorectal cancer. World J Gastroenterol 2016;22(5):1736–44. DOI:10.3748/wjg.v22.i5.1736.; Rodriguez-Salasa N., Dominguezb G., Barderasc R. et al. Clinical relevance of colorectal cancer molecular subtypes. Crit Rev Oncol Hematol 2017;109:9–19. DOI:10.1016/j.critrevonc.2016.11.007.; Aghagolzadeh P., Radpour R. New trends in molecular and cellular biomarker discovery for colorectal cancer. World J Gastroenterol 2016;22(25):5678–93. DOI:10.3748/wjg.v22.i25.5678.; Patel A., Tripathi G., Gopalakrishnan K. Field cancerisation in colorectal cancer: a new frontier or pastures past? World J Gastroenterol 2015;21(13):3763–72. DOI:10.3748/wjg.v21.i13.3763.; Podlaha O., Riester M., De S., Michor F. Evolution of the cancer genome. Trends Genet 2012;28(4):155–63. DOI:10.1016/j.tig.2012.01.003.; Joyce J.A., Fearon D.T. T-cell exclusion, immune privilege, and the tumor microenvironment. Science 2015;348(6230): 74–80. DOI:10.1126/science.aaa6204.; Palucka A.K., Coussens L.M. The basis of oncoimmunology. Cell 2016;164(6): 1233–47. DOI:10.1016/j.cell.2016.01.049.; Харченко E.П. Иммунное узнавание и иммунная привилегия. Иммунология 2008;29(2):118–24. [Kharchenko E.P. Immune recognition and immune privilege. Immunologiya = Immunology 2008;29(2):118–24. (In Russ.)].; Харченко Е.П. Иммунная привилегия: патологический aспект. Иммунология 2009;30(4):249–55. [Kharchenko E.P. Immune privilege: a pathological aspect. Immunologiya = Immunology 2009;30(4):249–55. (In Russ.)].; Suntsova M., Garazha A., Ivanova A. et al. Molecular functions of human endogenous retroviruses in health and disease. Cell Mol Life Sci 2015;72(19):3653–75. DOI:10.1007/s00018-015-1947-6.; Philippe P., Mullins C.S., Naville M. et al. Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes. Oncotarget 2015;6(37):40095–50111. DOI:10.18632/oncotarget.5539.; Díaz-Carballo D., Acikelli A.H., Klein J. et al. Therapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elements. J Exp Clin Cancer Res 2015;34:81. DOI 10.1186/s13046-015-0199-5.; Harrison M.M., Jenkins B.V., O’ConnorGiles K.M. et al. A CRISPR view of development. Genes Dev 2016;28(17): 1859–72. DOI:10.1101/gad.248252.114.
-
4Academic Journal
Συγγραφείς: O. A. Rachinskaya, V. A. Merkulov, О. А. Рачинская, В. А. Меркулов
Πηγή: Biological Products. Prevention, Diagnosis, Treatment; Том 18, № 1 (2018); 25-32 ; БИОпрепараты. Профилактика, диагностика, лечение; Том 18, № 1 (2018); 25-32 ; 2619-1156 ; 2221-996X ; 10.30895/2221-996X-2018-18-1
Θεματικοί όροι: кариотипирование, cell line, genetic instability, chromosomal abnormality, karyotyping, клеточная линия, генетическая нестабильность, хромосомные аномалии
Περιγραφή αρχείου: application/pdf
Relation: https://www.biopreparations.ru/jour/article/view/118/39; Федеральный закон от 23 июня 2016 г. № 180-ФЗ «О биомедицинских клеточных продуктах».; Mason C, Manzotti E. Regen: The Industry Responsible for Cell-Based Therapies. Regen Med. 2009; 4(6): 783–5.; Мельникова ЕВ, Меркулова ОВ, Рачинская ОА, Чапленко АА, Меркулов ВА, Олефир ЮВ и др. Современные подходы к проведению оценки качества препаратов для клеточной терапии. Биофармацевтический журнал 2016; 8(4): 35–46.; Duesberg P, Li R. Multistep Carcinogenesis: a Chain Reaction of Aneuploidizations. Cell Cycle 2003; 2(3): 202–10.; Rubio D, Garcia-Castro J, Martín MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A. Spontaneous Human Adult Stem Cell Transformation. Cancer Res. 2005; 65(8): 3035–9.; Бочков НП, Никитина ВА, Рослова ТА, Чаушев ИН, Якушина ИИ. Клеточная терапия наследственных болезней. Вестник РАМН 2008; (10): 20–8.; Goldring CE, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, et al. Assessing the Safety of Stem Cell Therapeutics. Cell Stem Cell 2011; 8(6): 618–28.; Geron. About GRNOPC1. Preclinical Safety Studies: Animal Toxicology Testing of GRNOPC1. Available from: http://ir.geron.com/phoenix.zhtml?c=67323&p=irolnewsArticle&ID=1636251; ALLOCORD (HPC Cord Blood). Package Insert. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM354696.pdf; LAVIV (Azficel-T). Package Insert and Patient Information Sheet. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM260489.pdf; CLEVECORD (HPC Cord Blood). Package Insert. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM519084.pdf; HEMACORD (HPC, cord blood). Package Insert. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM279612.pdf; DUCORD (HPC Cord Blood). Package Insert with Infusion Instructions. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM322732.pdf; HPC, Cord Blood. Package Insert. Available from: https://www. fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProdu cts/UCM305761.pdf; Epicel (Cultured Epidermal Autografts). Directions for Use. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM538555.pdf; Dermagraft (Interactive Wound Dressing). Summary of Safety and Effectiveness Data. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf/p000036b.pdf; Orcel (Bilayered Cellular Matrix) (Interactive Wound and Burn Dressing). Summary of Safety and Effectiveness Data. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf/p010016b.pdf; Holoclar (ex vivo Expanded Autologous Human Corneal Epithelial Cells Containing Stem Cells). EPAR Summary for the Public. EMEA/H/C/002450. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002450/WC500183406.pdf; Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products. Food and Drug Administration 2013. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryIn formation/Guidances/CellularandGeneTherapy/UCM376521.pdf; Guideline on Human Cell-Based Medicinal Products (EMEA/CHMP/410869/2006). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003894.pdf; Guidance for FDA Reviewers and Sponsors. Content and Review of Chemistry, Manufacturing, and Control (CMC). Information for Human Somatic Cell Therapy Investigational New Drug Applications (INDs). Food and Drug Administration 2008. Available from: https://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinf ormation/guidances/xenotransplantation/ucm092705.pdf; Carpenter MK, Frey-Vasconcells J, Rao MS. Developing Safe Therapies from Human Pluripotent Stem Cells. Nat Biotechnol. 2009; 27(7): 606–13.; Commission Directive 2009/120/EC of 14 September 2009 Amending Directive 2001/83/EC of the European Parliament and of the Council on the Community Code Relating to medicinal products for human use as Regards Advanced Therapy Medicinal Products. Available from: https://ec.europa.eu/health//sites/health/files/files/eudralex/vol- 1/dir_2009_120/dir_2009_120_en.pdf; Committee for Proprietary Medicinal Products (CPMP). Note for Guidance on the Quality, Preclinical and Clinical Aspects of Gene Transfer Medicinal Products (CPMP/BWP/3088/99). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500003987.pdf; Expert Committee on Biological Standardization. Recommendations for the Evaluation of Animal Cell Cultures as Substrates for the Manufacture of Biological Medicinal Products and for the Characterization of Cell Banks. Available from: http://www.who.int/biologicals/Cell_Substrates_clean_version_18_April.pdf; ICH Topic Q 5 D. Quality of Biotechnological Products: Derivation and Characterization of Cell Substrates Used for Production of Biotechnological/Biological Products (CPMP/ICH/294/95). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003280.pdf; Coecke S, Balls M, Bowe G, Davis J, Gstraunthaler G, Hartung T, et al. Guidance on Good Cell Culture Practice. A Report of the Second ECVAM Task Force on Good Cell Culture Practice. Altern Lab Anim. 2005; 33(3): 261–87.; Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research Purposes. Stem Cell Rev. 2009; 5(4): 301–14.; Астрелина ТА. Банк стволовых клеток: от науки к практике. М.: ЦНТБ ПП; 2015.; McGowan-Jordan J, Simons A, Schmid M, eds. An International System for Human Cytogenomic Nomenclature (ISCN). Basel, Freiburg: Karger; 2016.; Hayflick L. The Limited In Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res. 1965; 37: 614–36.; Мамаева СЕ. Закономерности кариотипической эволюции клеток в культуре. Цитология 1996; 38(8): 787–814.; Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S. Sarcoma Derived from Cultured Mesenchymal Stem Cells. Stem Cells 2007; 25(2); 371–9.; Borghesi A, Avanzini MA, Novara F, Mantelli M, Lenta E, Achille V, et al. Genomic Alterations in Human Umbilical Cord-Derived Mesenchymal Stromal Cells Call for Stringent Quality Control Before Any Possible Therapeutic Approach. Cytotherapy 2013; 15(11): 1362–73.; Ye CJ, Liu G, Bremer SW, Heng HH. The Dynamics of Cancer Chromosomes and Genomes. Cytogenet Genome Res. 2007; 118(2–4): 237–46.; Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, et al. Genomic Alterations in Cultured Human Embryonic Stem Cell. Nat Genet. 2005; 37(10): 1099–103.; Richards M, Tan S, Fong CY, Biswas A, Chan WK, Bongso A. Comparative Evalution of Various Human Feeders for Prolonged Undifferentiated Growth of Human Embryonic Stem Cells. Stem Cell 2003; 21(5): 546–56.; Skottman H, Hovatta O. Culture Conditions for Human Embryonic Stem Cells. Reproduction 2006; 132(5): 691–8.; Anisimov SV, Morizane A, Correia AS. Risks and Mechanisms of Oncological Disease Following Stem Cell Transplantation. Stem Cell Rev. 2010; 6(3): 411–24.; Ben-David U, Mayshar Y, Benvenisty N. Large-scale Analysis Reveals Acquisition of Lineage-Specific Chromosomal Aberrations in Human Adult Stem Cells. Cell Stem Cell 2011; 9(2): 97–102.; Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A. Human Bone Marrow Derived Mesenchymal Stem Cell do not Undergo Transformation after Long-Term in vitro Culture and Do Not Exhibit Telomere Maintenance Mechanisms. Cancer Res. 2007; 67(19): 9142–9.; Домнина АП, Фридлянская ИИ, Земелько ВИ, Пуговкина НА, Ковалева ЗВ, Зенин ВВ и др. Мезенхимные стволовые клетки эндометрия человека при длительном культивировании не подвергаются спонтанной трансформации. Цитология 2013; 55(1): 69–74.; Бочков НП, Воронина ЕС, Катосова ЛД, Никитина ВА. Цитогенетическое исследование мультипотентных мезенхимных стромальных клеток человека в процессе культивирования. Медицинская генетика 2009; 8(12): 3–6.; Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, et al. Clinical-Grade Production of Human Mesenchymal Stromal Cells: Occurrence of Aneuploidy without Transformation. Blood 2010; 115(8): 1549–53.; Попов БВ, Петров НС, Михайлов ВМ, Томилин АН, Алексеенко ЛЛ, Гринчук ТМ, Зайчик АМ. Спонтанная трансформация и иммортализация мезенхимных стволовых клеток в культуре in vitro. Цитология 2009; 51(2): 91–102.; Pan Q, Fouraschen SM, de Ruiter PE, Dinjens WN, Kwekkeboom J, Tilanus HW, van der Laan LJ. Detection of Spontaneous Tumorigenic Transformation during Culture Expansion of Human Mesenchymal Stromal Cells. Exp Biol Med (Maywood). 2014; 239(1): 105–15.; Barkholt L, Flory E, Jekerle V, Lucas-Samuel S, Ahnert P, Bisset L, et al. Risk of Tumorigenicity in Mesenchymal Stromal Cell-Based Therapies — Bridging Scientific Observations and Regulatory Viewpoints. Cytotherapy. 2013; 15(7): 753–9.; Полянская ГГ. Проблема нестабильности генома культивируемых стволовых клеток человека. Цитология 2014; 56(10): 697–707.; Wang Y, Huso DL, Harrington J, Kellner J, Jeong DK, Turney J, McNiece IK. Outgrowth of a Transformed Cell Population Derived from Normal Human BM Mesenchymal Stem Cell Culture. Cytotherapy 2005; 7(6): 509–19.; Peterson SE, Loring JF. Genomic Instability in Pluripotent Stem Cells: Implications for Clinical Applications. J Biol Chem. 2014; 289(8): 4578–84.; Мамева СЕ, Литвинчук ЛФ, Пинаев ГП. Закономерности кариотипической изменчивости в перевиваемых клеточных линиях человека. ДАН СССР 1983; 270(2): 456–8.; Mамаева СЕ. Атлас хромосом постоянных клеточных линий человека и животных. М.: Науч. мир; 2002.; Baronchelli S, Bentivegna A, Redaelli S, Riva G, Butta V, Paoletta L, et al. Delineating the Cytogenomic and Epigenomic Landscapes of Glioma Stem Cell Lines. PloS One 2013; 8(2): e57462.; Яковлева ТК, Ярцева НМ, Турилова ВИ. Прогрессия кариотипа клеточных линий острого миелобластного лейкоза человека. Клеточные культуры 2011; 27: 34–45.; Kowalczyk M, Srebniak M, Tomaszewska A. Chromosome Abnormalities without Phenotypic Consequences. J Appl Genet. 2007; 48(2): 157–66.; Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, et al. Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in Culture. Cell Stem Cell 2011; 8(1): 106–18.; Comings DE, Avelino E, Okada TA, Wyandt HE. The Mechanism of C- and G-Banding of Chromosomes. Exp Cell Res. 1973; 77(1): 469–83.; Sumner AT. Chromosome Banding and Identification Absorption Staining. In: Chromosome Analysis Protocols. Methods in Molecular Biology. Gosden GR, ed. Totowa: Humana Press; 1994. P. 59–81.; Speicher MR, Carter NP. The New Cytogenetics: Blurring the Boundaries with Molecular Biology. Nat Rev Genet. 2005; 6(10): 782–92.; Meisner LF, Johnson JA. Protocols for Cytogenetic Studies of Human Embryonic Stem Cells. Methods 2008; 45(2): 133–41.; Caspersson T, Zech L, Johansson C, Modest EJ. Identification of Human Chromosomes by DNA-Binding Fluorescent Agents. Chromosoma 1970; 30(2): 215–27.; Schweizer D, Ambros PF. Chromosome Banding. Stain Combinations for Specific Regions. Methods Mol Biol. 1994; 29: 97–112.; Schweizer D. Reverse Fluorescent Chromosome Banding with Chromomycin and DAPI. Chromosoma 1976; 58(4): 307–24.; Tobey RA, Crissman HA. Unique Techniques for Cell Analysis Utilizing Mithramycin and Flow Microfluorometry. Exp Cell Res. 1975; 93(1): 235–9.; Lin CC, Van de Sande JH. Differential Fluorescent Staining of Human Chromosomes with Daunomycin and Adriamycin — the D-Bands. Science 1975; 190(4209): 61–3.; Anderson R. Multiplex Fluorescence In Situ Hybridization (M-FISH). Methods Mol Biol. 2010; 659: 83–97.; du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, et al. Detection of Complete and Partial Chromosome Gains and Losses by Comparative Genomic In Situ Hybridization. Hum Genet. 1993; 90(6): 590–610.; Бочков НП. Клиническая генетика. М.: ГЭОТАР-МЕД; 2002.; Schmid W. The Micronucleus Test. Mutat Res. 1975; 31(1): 9–15.; Olive PL, Banáth JP. The Comet Assay: a Method to Measure DNA Damage in Individual Cells. Nat Protoc. 2006; 1(1): 23–9.; Theisen A. Microarray-Based Comparative Genomic Hybridization (aCGH). Nature Education 2008; 1(1): 45.; Kim S, Misra A. SNP Genotyping: Technologies and Biomedical Applications. Annu Rev Biomed Eng. 2007; 9: 289–320.; https://www.biopreparations.ru/jour/article/view/118
-
5Academic Journal
Συγγραφείς: V.S. Trifanov, O.I. Kit, E.N. Kolesnikov, N.S. Karnaukhov, E.M. Nepomnyaschaya, N.N. Timoshkina, A.V. Snezhko, M.Y. Meshcheriakova, A.L. Bazaev
Πηγή: Yakut Medical Journal. :124-125
Θεματικοί όροι: gastric neuroendocrine tumor, нейроэндокринная опухоль желудка, intratumoral heterogeneity, somatostatin receptors, соматостатиновые рецепторы, genetic instability, генетическая нестабильность, 3. Good health, внутриопухолевая гетерогенность
-
6Academic Journal
Συγγραφείς: Дёмина, Э.
Θεματικοί όροι: ИОНИЗИРУЮЩАЯ РАДИАЦИЯ, ЧЕРНОБЫЛЬСКАЯ АВАРИЯ, ГЕНЕТИЧЕСКАЯ НЕСТАБИЛЬНОСТЬ, ЩИТОВИДНАЯ ЖЕЛЕЗА, РАДИОГЕННЫЙ РАК
Περιγραφή αρχείου: text/html
-
7Academic Journal
Συγγραφείς: Кузин, Сергей, Маркина, Валерия
Θεματικοί όροι: БИОРИТМ, КЛЕТОЧНЫЙ ЦИКЛ, ДЕСИНХРОНОЗ, ГЕНЕТИЧЕСКАЯ НЕСТАБИЛЬНОСТЬ
Περιγραφή αρχείου: text/html
-
8Academic Journal
Πηγή: Радиация и риск (Бюллетень Национального радиационно-эпидемиологического регистра).
Περιγραφή αρχείου: text/html
-
9Academic Journal
Συγγραφείς: Баленко, Н. В., Осташ, О. М.
Θεματικοί όροι: окружающая среда, навколишнє природне середовище, генетическая нестабильность организма, генетична нестабільність організму
Διαθεσιμότητα: http://ir.nmu.org.ua/handle/123456789/150996
-
10Academic Journal
Συγγραφείς: Надыров, Э., Мельнов, С., Малиновская, Ю., Путырский, Л., Сарана, Ю.
Περιγραφή αρχείου: text/html
-
11Academic Journal
Πηγή: ScienceRise; Том 2, № 4(7) (2015); 23-30
Θεματικοί όροι: ionizing radiation, Chernobyl accident, genetic instability, thyroid, radiogenic cancer, ионизирующая радиация, Чернобыльская авария, генетическая нестабильность, щитовидная железа, радиогенный рак, 0211 other engineering and technologies, УДК 616.441-006-089-053, 02 engineering and technology, 0204 chemical engineering, 3. Good health
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://journals.uran.ua/sciencerise/article/view/37682
-
12Academic Journal
Πηγή: Здоровье и образование в XXI веке.
Περιγραφή αρχείου: text/html
-
13Academic Journal
Πηγή: Журнал Гродненского государственного медицинского университета.
Θεματικοί όροι: РАК МОЛОЧНОЙ ЖЕЛЕЗЫ, ГЕНЕТИЧЕСКАЯ НЕСТАБИЛЬНОСТЬ, ПАТОЛОГИЧЕСКИЕ МИТОЗЫ, МИКРОЯДРА, 3. Good health
Περιγραφή αρχείου: text/html
-
14Academic Journal
Συγγραφείς: Мельнов, С. Б., Надыров, Э. А., Дрозд, Т. Г., Тимофеенко, Е. С., Путырский, Л. А.
Θεματικοί όροι: рак молочной железы, генетическая нестабильность, микроядра, митозы
Relation: Цитогенетический и цитологический статус рака молочной железы у лиц, проживающих на территории Гомельской области / С.Б. Мельнов и др. // Проблемы здоровья и экологии. - 2006. - №1(7). - С.55-59.; http://elib.gsmu.by/handle/GomSMU/1068
Διαθεσιμότητα: http://elib.gsmu.by/handle/GomSMU/1068
-
15Academic Journal
Συγγραφείς: Rozumenko, V. D., Glavatskiy, A. Ya., Vasilyeva, I. G., Chopick, N. G., Lysenko, S. M.
Πηγή: Український нейрохірургічний журнал; № 3 (2004); 4-13
Украинский нейрохирургический журнал; № 3 (2004); 4-13
Ukrainian Neurosurgical Journal; № 3 (2004); 4-13Θεματικοί όροι: apoptosis, carcinogenesis, oncogene, neoangiogenesis, genetic instability, glutathione S-transferase, апоптоз, канцерогенез, онкоген, неоангиогенез, генетическая нестабильность, глутатион S-трансфераза, 3. Good health, неоангіогенез, генетична нестабільність, глутатіон S-трансфераза
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://theunj.org/article/view/144403
